Application of A-type ultrasonic waves to development of myopia-related drugs
An ultrasound and drug technology, applied in the application field of A-type ultrasound in the development of myopia-related drugs, can solve the problems of complicated and time-consuming process, high technical difficulty, high experimental cost, and achieve no damage to the whole body, good repeatability, and high technology. stable effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] 1. Experimental materials and methods:
[0043] Experimental animals: 12 healthy juvenile cynomolgus monkeys with normal eyes were selected, aged 45.9 months ± 2.4 months (equivalent to the age of puberty in humans), mean ± standard deviation (the same below), weight 3.8 ± 0.6 kg, male and female half and half.
[0044] Drugs to be tested: 1.0% atropine sulfate eye drops (Day Point, Nagoya) and 0.5%, 0.1%, 0.05% and 0.01% atropine eye drops diluted with neutral phosphate buffer.
[0045] Control substance: neutral phosphate buffer solution (PBS, pH=7.4).
[0046] Administration method: a single topical eye drop, 30 μl per eye, administered to both eyes at the same time.
[0047] Testing instrument: ophthalmology A / B type ultrasonic diagnostic instrument (ODM-2100S, Tianjin Maida Medical Technology)
[0048] ODM-2100S ophthalmology type A eye axis biological parameter measurement part technical indicators:
[0049] Ultrasonic frequency 10MHz
[0050] Measurement accu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com